Dyne Therapeutics
DYN
15.50
-0.53
-3.31%
Dyne Therapeutics
US · DYN
#2540 by market cap
Listed 2020
15.50
-0.53
-3.31%
Periodic snapshot; not a real-time feed.
· 2026-11-20 19:30
Quant vs Street three independent views, side by side
StockVane factor grade
B-
Momentum strategy signal
Sell
Analyst consensus
Buy
Mostly aligned, one view stands apart.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
✦ Quant Analyst Revision Trend how this is computed
Mixed
1
■ Upgrades■ Downgrades
- 0 upgrades vs 1 downgrade among tracked analyst rating changes.
- Most recent: J.P. Morgan moved from Hold to Sell on 2026-09-08.
Analyst consensus 10 analysts
Buy
Avg price target 34.90 +125.2%
Price target rangecurrent 15.50
Low10.00
Avg34.90
High50.00
Buy 90%
Hold 0%
Sell 10%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-11-11 | Raymond James | -- | Buy | 41.00 |
| 2026-11-06 | Morgan Stanley | -- | Buy | 36.00 |
| 2026-11-06 | H.C. Wainwright | -- | Buy | 32.00 |
| 2026-11-05 | RBC Capital | -- | Buy | 30.00 |
| 2026-09-30 | LifeSci Capital | -- | Buy | 40.00 |
| 2026-09-30 | Stifel | -- | Buy | 37.00 |
| 2026-09-30 | H.C. Wainwright | -- | Buy | 32.00 |
| 2026-09-29 | Piper Sandler | -- | Buy | 47.00 |
| 2026-09-23 | Raymond James | -- | Buy | 37.00 |
| 2026-09-09 | Baird | -- | Buy | 26.00 |
| 2026-09-09 | Morgan Stanley | -- | Buy | 36.00 |
| 2026-09-08 | LifeSci Capital | -- | Buy | 40.00 |
| 2026-09-08 | Jefferies | -- | Buy | 50.00 |
| 2026-09-08 | Stifel | -- | Buy | 37.00 |
| 2026-09-08 | RBC Capital | -- | Buy | 30.00 |
| 2026-09-08 | J.P. Morgan | -- | Sell | 10.00 |
| 2026-08-25 | Raymond James | -- | Buy | 40.00 |
| 2026-08-04 | Raymond James | -- | Buy | 40.00 |
| 2026-07-31 | LifeSci Capital | -- | Buy | 44.00 |
| 2026-07-31 | Morgan Stanley | -- | Buy | 45.00 |
| 2026-07-31 | Stifel | -- | Buy | 37.00 |
| 2026-07-30 | Piper Sandler | -- | Buy | 47.00 |
| 2026-07-30 | J.P. Morgan | -- | Hold | -- |
| 2026-07-29 | Chardan Capital | -- | Buy | 38.00 |
| 2026-07-29 | LifeSci Capital | -- | Buy | 44.00 |
Price target trend monthly average, last 3 years
Recent rating changes
| Date | Firm | Change | Target |
|---|---|---|---|
| 2026-09-08 | J.P. Morgan | Hold → Sell | 10.00 |
Quote time 2026-11-20 19:30:05 · For reference only, not investment advice and not tailored to your situation.
Dyne Therapeutics discussion 0 comments